Snowflake, Vertex Pharmaceuticals, Chewy & more


Take a look at some of the biggest movers in the premarket:

Snowflake (SNOW) – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target of reaching $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January.

Vertex Pharmaceuticals (VRTX) – The drugmaker halted development of an experimental drug designed to treat a rare genetic disease called AAT Deficiency. Vertex said the drug raised levels of a deficient protein, but not enough to provide a substantial benefit. Vertex plunged 13.9% in the premarket.

Chewy (CHWY)…


Cement firm works with GE’s renewables unit on wind turbine recycling 

Previous article

Dr. Scott Gottlieb on rare heart inflammation in young Covid vaccine recipients

Next article

You may also like

Leave a Reply

Notify of

More in Finance